Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lilly and Scios extend Alzheimer's research collaboration

June 5, 2000

Combination of psycho- and drug therapy most efficacious for chronic depression

June 5, 2000

Inhibitors of nitric oxide synthase synthesized at Schering AG

June 2, 2000

Use of pregabalin and related compounds for mania and bipolar disorder

June 2, 2000

BLS initiates inosine development program as stroke therapy

June 2, 2000

Suntory researchers discover novel neuroprotective agents

June 1, 2000

Janssen evaluating combination therapies for Alzheimer's disease and psychosis

June 1, 2000

Ceramide derivatives synthesized at Otsuka may have potential in cognitive disorders, inflammation

June 1, 2000

Combined therapy with estrogen and T-cell receptor protein for MS

June 1, 2000

Centaur announces phase IIa stroke trial results

May 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...